JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy

Kidney International

Volumn 84, Issue 6, 2013, Pages 1207-1213

  Divers, Jasmin ^a   Núñez, Marina ^a   High, Kevin P ^a   Murea, Mariana ^a   Rocco, Michael V ^a   Ma, Lijun ^a   Bowden, Donald W ^a   Hicks, Pamela J ^a   Spainhour, Mitzie ^a   Ornelles, David A ^a   Kleiboeker, Steven B ^b   Duncan, Kara ^b   Langefeld, Carl D ^a   Turner, JoLyn ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ViraCor IBT Laboratories   (United States)

Author keywords

APOL1; BK polyoma virus; HIV; JC polyoma virus; proteinuria

Indexed keywords

CYSTATIN C; VIRUS DNA;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; ALLELE; APOL1 GENE; ARTICLE; BK VIRUS INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN HERPESVIRUS 6; JC VIRUS INFECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK FACTOR; URINALYSIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ADULT; AFRICAN AMERICANS; AGED; ALBUMINURIA; APOLIPOPROTEINS; CHI-SQUARE DISTRIBUTION; CYSTATIN C; DNA, VIRAL; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; JC VIRUS; KIDNEY DISEASES; LINEAR MODELS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; NORTH CAROLINA; PHENOTYPE; POLYOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; TUMOR VIRUS INFECTIONS;

EID: 84888636557     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.173     Document Type: Article

References (34)

1. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
2. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350.
3. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-Associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137.
4. Freedman BI, Kopp JB, Langefeld CD et al. The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426.
5. Bostrom MA, Freedman BI. The spectrum of MYH9-Associated nephropathy. Clin J Am Soc Nephrol 2010; 5: 1107-1113.
6. Bostrom MA, Kao WH, Li M et al. Genetic Association and Gene-Gene Interaction Analyses in African American Dialysis Patients With Nondiabetic Nephropathy. Am J Kidney Dis 2011; 59: 210-221.
7. Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344: 1979-1984.
8. D'Agati V, Suh JI, Carbone L et al. Pathology of HIV-Associated nephropathy: A detailed morphologic and comparative study. Kidney Int 1989; 35: 1358-1370.
9. Lipkowitz M, Freedman BI, Langefeld CD et al. Apolipoprotein L1 gene variants associate with hypertension-Attributed nephropathy and the rate of the kidney function decline in African Americans. Kidney Int 2012; 83: 114-120.
10. Friedman DJ, Kozlitina J, Genovese G et al. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22: 2098-2105.
11. Freedman BI, Langefeld CD, Turner J et al. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int 2012; 82: 805-811.
12. Hollander M, Gordon P, Lin PE. Robustness of the Wilcoxon Test to a certain dependency between samples. The Annals of Statistics 1974; 2: 177-181.
13. McCance DJ. Persistence of animal and human papovaviruses in renal and nervous tissues. Prog Clin Biol Res 1983; 105: 343-357.
14. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006; 577: 19-45.
15. Doerries K. Human polyomavirus JC and BK persistent infection. Adv Exp Med Biol 2006; 577: 102-116.
16. Kitamura T, Aso Y, Kuniyoshi N et al. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161: 1128-1133.
17. Pires EP, Bernardino-Vallinoto CV, Alves DM et al. Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease. Transpl Infect Dis 2011; 13: 633-637.
18. Egli A, Infanti L, Dumoulin A et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
19. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147: 676-684.
20. Tominaga T, Yogo Y, Kitamura T et al. Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients. Virology 1992; 186: 736-741.
21. Cheng XS, Bohl DL, Storch GA et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol 2011; 22: 825-831.
22. Kantarci G, Eren Z, Demirag A et al. JC virus-Associated nephropathy in a renal transplant recipient and comparative analysis of previous cases. Transpl Infect Dis 2011; 13: 89-92.
23. Lopez V, Gutierrez C, Sola E et al. Does JC polyomavirus cause nephropathy in renal transplant patients? Transplant Proc 2010; 42: 2889-2891.
24. Saundh BK, Tibble S, Baker R et al. Different patterns of BK and JC polyomavirus reactivation following renal transplantation. J Clin Pathol 2010; 63: 714-718.
25. Querbes W, O'Hara BA, Williams G et al. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 2006; 80: 9402-9413.
26. Moriyama T, Marquez JP, Wakatsuki T et al. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J Virol 2007; 81: 8552-8562.
27. Eash S, Manley K, Gasparovic M et al. The human polyomaviruses. Cell Mol Life Sci 2006; 63: 865-876.
28. Skorecki KL, Wasser WG. Hypertension-misattributed kidney disease in African Americans. Kidney Int 2013; 83: 6-9.
29. Freedman BI, Langefeld CD, Murea M et al. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant 2011; 26: 3805-3810.
30. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
31. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009; 150: 604-612.
32. Tang H, Peng J, Wang P et al. Estimation of individual admixture: Analytical and study design considerations. Genet Epidemiol 2005; 28: 289-301.
33. Box GEP, Cox DR. An analysis of tranformations. J Roy Stat Soc Ser B 1964; 26: 211-246.
34. Manichaikul A, Chen WM, Williams K et al. Analysis of family- And population-based samples in cohort genome-wide association studies. Hum Genet 2012; 131: 275-287.